You are here

  • Home
  • Archive
  • Volume 77, Issue 1
  • Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD

Article info

Article menu
Chronic obstructive pulmonary disease
Original research
Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD

Authors

  • Elizabeth J Becker Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA Bioinformatics Program, Boston University, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Alen Faiz Respiratory Bioinformatics and Molecular Biology (RBMB), School of Life Sciences, University of Technology Sydney, Sydney, New South Wales, Australia Department of Pulmonary Diseases, University Medical Center Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Maarten van den Berge Department of Pulmonary Diseases, University Medical Center Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Wim Timens Department of Pathology and Medical Biology, University Medical Centre Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Pieter S Hiemstra Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands PubMed articlesGoogle scholar articles
  • Kristopher Clark Internal Medicine Residency Program, Boston Medical Center, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Gang Liu Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Xiaohui Xiao Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Yuriy O Alekseyev Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • George O'Connor Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Stephen Lam British Columbia Cancer Agency, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Avrum Spira Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA Bioinformatics Program, Boston University, Boston, Massachusetts, USA Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Marc E Lenburg Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA Bioinformatics Program, Boston University, Boston, Massachusetts, USA Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Katrina Steiling Division of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, USA Bioinformatics Program, Boston University, Boston, Massachusetts, USA Division of Pulmonary, Allergy, Sleep, and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Katrina Steiling, Division of Computational Biomedicine, Boston University School of Medicine, Boston, MA 02118, USA; steiling{at}bu.edu
View Full Text

Citation

Becker EJ, Faiz A, van den Berge M, et al
Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD
Thorax 2022;77:31-39.

Publication history

  • Received December 19, 2019
  • Revised February 10, 2021
  • Accepted April 8, 2021
  • First published May 10, 2021.
Online issue publication 
September 01, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.